BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1 – 10 of 1818
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
- Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effects
- Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease
- Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
- Statin use and breast cancer survival - A Swedish nationwide study
- Tuning the protein phosphorylation by receptor type protein tyrosine phosphatase epsilon (PTPRE) in normal and cancer cells
- Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
- Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk
- Afadin cooperates with Claudin-2 to promote breast cancer metastasis
- Assessing Automated Sample Preparation Technologies for High-Throughput Proteomics of Frozen Well Characterized Tissues from Swedish Biobanks